The management of risk and investment in cell therapy process development: a case study for neurodegenerative disease. (2019)
Attributed to:
EPSRC Fellowships in Manufacturing - Regenerative Medicine Manufacture: A Systems Based Research Platform
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/rme-2018-0081
PubMed Identifier: 31210581
Publication URI: http://europepmc.org/abstract/MED/31210581
Type: Journal Article/Review
Volume: 14
Parent Publication: Regenerative medicine
Issue: 5
ISSN: 1746-0751